Skip to main content

Benzylaminopurine

ADVERTISEMENT
Identification
Molecular formula
C12H11N5O
CAS number
525-79-1
IUPAC name
2-[[6-(benzylamino)-9-methyl-purin-2-yl]amino]ethanol
State
State

At room temperature, benzylaminopurine is in a solid state. It is commonly used in scientific research and horticulture as a plant growth regulator.

Melting point (Celsius)
230.00
Melting point (Kelvin)
503.00
Boiling point (Celsius)
689.30
Boiling point (Kelvin)
962.50
General information
Molecular weight
225.26g/mol
Molar mass
225.2630g/mol
Density
1.3910g/cm3
Appearence

Benzylaminopurine appears as a white to off-white crystalline powder. It is typically odorless.

Comment on solubility

Solubility of 2-[[6-(benzylamino)-9-methyl-purin-2-yl]amino]ethanol (C12H11N5O)

The solubility of 2-[[6-(benzylamino)-9-methyl-purin-2-yl]amino]ethanol is an interesting aspect that can influence its applications in various fields. This compound exhibits unique characteristics that contribute to its solubility profile:

  • Polar vs Nonpolar Nature: The presence of hydroxyl groups (–OH) makes the molecule slightly polar, which generally increases solubility in polar solvents such as water.
  • Hydrogen Bonding: The ability to form hydrogen bonds due to its amino and hydroxyl groups enhances its interaction with solvent molecules, further aiding in solubility.
  • Structural Complexity: The complex structure involving purine derivatives and a benzyl group may also affect solubility, potentially limiting it in nonpolar solvents.

In summary, the solubility of this compound suggests that it is likely more soluble in polar solvents due to its functional groups, while its solubility in nonpolar solvents may be significantly lower. Testing under various conditions is recommended to fully understand its solubility and potential applications.

Interesting facts

Interesting Facts about 2-[[6-(Benzylamino)-9-methyl-purin-2-yl]amino]ethanol

This compound, known as 2-[[6-(benzylamino)-9-methyl-purin-2-yl]amino]ethanol, is a fascinating example within the realm of synthetic organic chemistry. Here are several noteworthy aspects concerning its structure and potential applications:

  • Complex Structure: The presence of a purine base, along with an amino group, implies that this compound may play a significant role in biochemical processes akin to those that drive nucleic acids in living organisms.
  • Potential Therapeutic Applications: Due to its purine-like structure, this compound could be studied for its pharmacological effects, particularly in the realms of anticancer or antiviral activity. The structural similarities to compounds like adenosine can suggest important biological interactions.
  • Research Interest: Scientists are increasingly interested in derivatives of purines, as they have been linked to a variety of physiological functions, including cellular signaling and regulation.
  • Drug Design: The functionality provided by the benzylamino and ethanol moieties may enable this compound to serve as a lead structure in drug discovery, allowing for the design of more specific and effective therapeutics.
  • Analytical Methods: Techniques such as NMR and mass spectrometry can be employed to further investigate the properties and behaviors of this compound, potentially leading to the identification of additional applications.

In summary, 2-[[6-(benzylamino)-9-methyl-purin-2-yl]amino]ethanol is not just a chemical compound, but rather a stepping stone towards understanding crucial biological mechanisms and developing novel therapeutic agents. As the field of medicinal chemistry evolves, the exploration of compounds like this one continues to hold promise for future scientific breakthroughs.

Synonyms
olomoucine
101622-51-9
Olomucine
6-(Benzylamino)-2-(2-hydroxyethylamino)-9-methylpurine
2-(2-Hydroxyethylamino)-6-benzylamino-9-methylpurine
NSC-666096
2-((6-(Benzylamino)-9-methyl-9H-purin-2-yl)amino)ethanol
4erk
Ethanol, 2-[[9-methyl-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-
2-{[6-(benzylamino)-9-methyl-9h-purin-2-yl]amino}ethanol
6A839B2HYS
2-(2-Hydroxyethylamino)-6-(benzylamino)-9-methylpurine
MFCD00189360
NSC 666096
2-(Hydroxyethylamino)-6-benzylamino-9-methylpurine
6-Benzylamino-2-(2-hydroxyethylamino)-9-methylpurine
CHEMBL280074
CHEBI:44661
2-{[6-(benzylamino)-9-methyl-9H-purin-2-yl]amino}ethan-1-ol
DTXSID90144068
ethanol, 2-((9-methyl-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-
6-benzylamino-2-[2-hydroxyethylamino]-9-methylpurine
OLO
2-[[9-Methyl-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-ethanol
2-(2-Hydroxyethylamino)-6-benzylamino-9-isopropylpurine
2-((6-(benzylamino)-9-methyl-9H-purin-2-yl)amino)ethan-1-ol
SR-01000075518
UNII-6A839B2HYS
2-[[6-(benzylamino)-9-methylpurin-2-yl]amino]ethanol
Olomoucine?
2-((9-methyl-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-ethanol
purine deriv. 5
N2-[(2-Hydroxyethyl)-N6-benzyladenine; 6-(Benzylamino)-2-(2-hydroxyethylamino)-9-methylpurine; NSC 666096;
Kinome_2870
Tocris-1284
1w0x
BiomolKI_000046
Lopac-O-0886
BiomolKI2_000052
UPCMLD-DP136
CBiol_002050
Lopac0_000883
BSPBio_000990
KBioGR_000330
KBioSS_000330
SCHEMBL135056
6-Benylamino-2-(2-hydroxyethylamino)-9-methylpurine
BDBM5718
BMK1-E10
DTXCID8066559
Olomoucine, >=98% (HPLC)
UPCMLD-DP136:001
UPCMLD-DP136:002
BCBcMAP01_000205
KBio2_000330
KBio2_002898
KBio2_005466
KBio3_000659
KBio3_000660
Bio1_000336
Bio1_000825
Bio1_001314
Bio2_000335
Bio2_000815
HMS1362B11
HMS1792B11
HMS1990B11
HMS3262B08
HMS3267L09
HMS3403B11
HMS3412E10
HMS3650F19
HMS3676E10
Tox21_500883
NSC666096
AKOS005145988
CCG-100650
CS-W012144
DB02116
HY-W011428
LP00883
SDCCGSBI-0050858.P002
SDCCGSBI-0050858.P005
IDI1_002090
Olomoucine - CAS 101622-51-9
SMP1_000281
2,6,9-Trisubstituted purine deriv. 26
NCGC00015763-01
NCGC00015763-02
NCGC00015763-03
NCGC00015763-04
NCGC00015763-05
NCGC00015763-06
NCGC00015763-07
NCGC00015763-08
NCGC00015763-09
NCGC00025096-01
NCGC00025096-02
NCGC00025096-03
NCGC00025096-04
NCGC00025096-05
NCGC00025096-06
NCGC00025096-07
NCGC00261568-01
MS-24291
NCI60_022916
EU-0100883
NS00015168
F85617
O 0886
SR-01000075518-1
SR-01000075518-3
SR-01000075518-6
BRD-K82731415-001-03-9
BRD-K82731415-001-04-7
BRD-K82731415-001-07-0
Q27093184
2-[[6-(benzylamino)-9-methyl-purin-2-yl]amino]ethanol
2-(6-(benzylamino)-9-methyl-9H-purin-2-ylamino)ethanol
6-(benzylamino)-2-[(2-hydroxyethyl)amino]-9-methylpurine
2-[[9-methyl-6-(phenylmethylamino)purin-2-yl]amino]ethanol
2-[[9-Methyl-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]ethanol
2-[[9-Methyl-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]ethanol, 9CI